Zydus Lifesciences Announces Q4 Numbers with ₹2.2 Billion One-Time Impairment Charge

Unknown Apr 02, 2026 4 Views

Zydus Lifesciences released its Q4 FY25 quarterly results, reporting a ₹2.2 billion one-time charge, which affected its net profit. The company, however, reported robust revenue growth with consolidated revenue from operations coming in at ₹65.28 billion, higher than the IBES estimate of ₹64.61 b...